Maternal testosterone and placental function: Effect of electroacupuncture on placental expression of angiogenic markers and fetal growth

Molecular and Cellular Endocrinology

Volumn 433, Issue , 2016, Pages 1-11

  Fornes, Romina ^a   Hu, Min ^a   Maliqueo, Manuel ^b   Kokosar, Milana ^c   Benrick, Anna ^c   Carr, David ^d   Billig, Håkan ^c   Jansson, Thomas ^e   Manni, Luigi ^f   Stener Victorin, Elisabet ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF COLORADO   (United States)

^f INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Acupuncture; Electrical stimulation; Fetus; Maternal androgen excess; Placenta; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; CORTICOSTERONE; NERVE GROWTH FACTOR; NORADRENALIN; STEROID RECEPTOR; TESTOSTERONE; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DAM (ANIMAL); ELECTROACUPUNCTURE; ELECTROSTIMULATION; FEMALE; FETUS; FETUS GROWTH; FETUS WEIGHT; GENOTYPE; GESTATION PERIOD; HUMAN; MATERNAL BLOOD; NEUROTROPISM; NONHUMAN; PLACENTA; PLACENTA FUNCTION; PLACENTA WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEROIDOGENESIS; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; ANIMAL; BLOOD PRESSURE; FETUS DEVELOPMENT; METABOLISM; OVARY POLYCYSTIC DISEASE; PHYSIOLOGY; PREGNANCY; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOOD PRESSURE; CORTICOSTERONE; ELECTROACUPUNCTURE; FEMALE; FETAL DEVELOPMENT; FETUS; PLACENTA; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RATS; RATS, WISTAR; TESTOSTERONE;

EID: 84969961864     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.05.014     Document Type: Article

References (68)

1. Abbott D.H., Barnett D.K., Levine J.E., Padmanabhan V., Dumesic D.A., Jacoris S., Tarantal A.F. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol. Reprod. 2008, 79(1):154-163.
2. Abbott D.H., Tarantal A.F., Dumesic D.A. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am. J. Primatol. 2009, 71(9):776-784.
3. Al-Gayyar M.M., Mysona B.A., Matragoon S., Abdelsaid M.A., El-Azab M.F., Shanab A.Y., Ha Y., Smith S.B., Bollinger K.E., El-Remessy A.B. Diabetes and overexpression of proNGF cause retinal neurodegeneration via activation of RhoA pathway. PLoS One. 2013, 8(1):e54692.
4. Anderson H., Fogel N., Grebe S.K., Singh R.J., Taylor R.L., Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J. Clin. Endocrinol. Metab. 2010, 95(5):2180-2186.
5. Bai Y.H., Lim S.C., Song C.H., Bae C.S., Jin C.S., Choi B.C., Jang C.H., Lee S.H., Pak S.C. Electro-acupuncture reverses nerve growth factor abundance in experimental polycystic ovaries in the rat. Gynecol. Obstet. Invest. 2004, 57(2):80-85.
6. Barry J.A., Kay A.R., Navaratnarajah R., Iqbal S., Bamfo J.E., David A.L., Hines M., Hardiman P.J. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J. Obstet. Gynaecol. 2010, 30(5):444-446.
7. Bierl M.A., Jones E.E., Crutcher K.A., Isaacson L.G. 'Mature' nerve growth factor is a minor species in most peripheral tissues. Neurosci. Lett. 2005, 380(1-2):133-137.
8. Birch R.A., Padmanabhan V., Foster D.L., Unsworth W.P., Robinson J.E. Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology 2003, 144(4):1426-1434.
9. Boomsma C.M., Eijkemans M.J., Hughes E.G., Visser G.H., Fauser B.C., Macklon N.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update. 2006, 12(6):673-683.
10. Brauer M.M. Cellular and molecular mechanisms underlying plasticity in uterine sympathetic nerves. Auton. Neurosci. 2008, 140(1-2):1-16.
11. Caanen M.R., Kuijper E.A., Hompes P.G., Kushnir M.M., Rockwood A.L., Meikle W.A., Homburg R., Lambalk C.B. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome. Eur. J. Endocrinol. 2016, 174(1):25-32.
12. Carter J.R. Sympathetic neural tone: large and in charge throughout pregnancy. J. Physiol. 2012, 590(Pt 15):3411-3412.
13. Cerdeira A.S., Karumanchi S.A. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb. Perspect. Med. 2012, 2(11).
14. Chinnathambi V., Blesson C.S., Vincent K.L., Saade G.R., Hankins G.D., Yallampalli C., Sathishkumar K. Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries. Hypertension 2014, 64(2):405-414.
15. Doherty D.A., Newnham J.P., Bower C., Hart R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet. Gynecol. 2015, 125(6):1397-1406.
16. Falbo A., Rocca M., Russo T., D'Ettore A., Tolino A., Zullo F., Orio F., Palomba S. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J. Ovarian Res. 2010, 3:23.
17. Feng Y., Johansson J., Shao R., Manneras-Holm L., Billig H., Stener-Victorin E. Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5alpha-dihydrotestosterone-induced rat polycystic ovary syndrome model. Exp. Physiol. 2012, 97(5):651-662.
18. Frank P., Barrientos G., Tirado-Gonzalez I., Cohen M., Moschansky P., Peters E.M., Klapp B.F., Rose M., Tometten M., Blois S.M. Balanced levels of nerve growth factor are required for normal pregnancy progression. Reproduction 2014, 148(2):179-189.
19. Gopalakrishnan K., Mishra J.S., Chinnathambi V., Vincent K.L., Patrikeev I., Motamedi M., Saade G.R., Hankins G.D., Sathishkumar K. Elevated testosterone reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant rats. Hypertension 2016, 67(3):630-639.
20. Hempstead B.L. Deciphering proneurotrophin actions. Handb. Exp. Pharmacol. 2014, 220:17-32.
21. Hentges C.R., Silveira R.C., Procianoy R.S. Angiogenic and antiangiogenic factors in preterm neonates born to mothers with and without preeclampsia. Am. J. Perinatol. 2015, 32(12):1185-1190. http://dx.doi.org/10.1055/s-0035-1552932.
22. Hickey M., Sloboda D.M., Atkinson H.C., Doherty D.A., Franks S., Norman R.J., Newnham J.P., Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J. Clin. Endocrinol. Metab. 2009, 94(10):3714-3720.
23. Hu S., Leonard A., Seifalian A., Hardiman P. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum. Reprod. 2007, 22(6):1532-1539.
24. Hu M., Richard J.E., Maliqueo M., Kokosar M., Fornes R., Benrick A., Jansson T., Ohlsson C., Wu X., Skibicka K.P., Stener-Victorin E. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. Proc. Natl. Acad. Sci. U. S. A. 2015, 112(46):14348-14353.
25. Jamal A., Milani F., Al-Yasin A. Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran. J. Reprod. Med. 2012, 10(3):265-270.
26. Jarvis S.S., Shibata S., Bivens T.B., Okada Y., Casey B.M., Levine B.D., Fu Q. Sympathetic activation during early pregnancy in humans. J. Physiol. 2012, 590(Pt 15):3535-3543.
27. Johansson J., Manneras-Holm L., Shao R., Olsson A., Lonn M., Billig H., Stener-Victorin E. Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling. PLoS One. 2013, 8(1):e54357.
28. Kimura A., Sato A. Somatic regulation of autonomic functions in anesthetized animals-neural mechanisms of physical therapy including acupuncture. Jpn. J. Vet. Res. 1997, 45(3):137-145.
29. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987, 237(4819):1154-1162.
30. Lobos E., Gebhardt C., Kluge A., Spanel-Borowski K. Expression of nerve growth factor (NGF) isoforms in the rat uterus during pregnancy: accumulation of precursor proNGF. Endocrinology 2005, 146(4):1922-1929.
31. MacGrogan D., Saint-Andre J.P., Dicou E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J. Neurochem. 1992, 59(4):1381-1391.
32. MacPherson H., Hammerschlag R., Coeytaux R.R., Davis R.T., Harris R.E., Kong J.T., Langevin H.M., Lao L., Milley R.J., Napadow V., Schnyer R.N., Stener-Victorin E., Witt C.M., Wayne P.M. Unanticipated insights into biomedicine from the study of acupuncture. J. Altern. Complement. Med. 2016, 22(2):101.
33. Maliqueo M., Lara H.E., Sanchez F., Echiburu B., Crisosto N., Sir-Petermann T. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 166(2):151-155.
34. Maliqueo M., Benrick A., Alvi A., Johansson J., Sun M., Labrie F., Ohlsson C., Stener-Victorin E. Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or beta-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome. Mol. Cell Endocrinol. 2015, 412:159-169.
35. Manneras L., Jonsdottir I.H., Holmang A., Lonn M., Stener-Victorin E. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 2008, 149(7):3559-3568.
36. Manni L., Lundeberg T., Holmang A., Aloe L., Stener-Victorin E. Effect of electro-acupuncture on ovarian expression of alpha (1)- and beta (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Reprod. Biol. Endocrinol. 2005, 3(1):21.
37. Mehrabian F., Kelishadi R. Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls. J. Res. Med. Sci. 2012, 17(3):207-211.
38. Palomba S., Falbo A., Russo T., Battista L., Tolino A., Orio F., Zullo F. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG 2010, 117(6):711-721.
39. Palomba S., Falbo A., Chiossi G., Tolino A., Tucci L., La Sala G.B., Zullo F. Early trophoblast invasion and placentation in women with different PCOS phenotypes. Reprod. Biomed. Online. 2014, 29(3):370-381.
40. Pandolfi C., Zugaro A., Lattanzio F., Necozione S., Barbonetti A., Colangeli M.S., Francavilla S., Francavilla F. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome. Metabolism 2008, 57(7):999-1004.
41. Perez-Sepulveda A., Monteiro L.J., Dobierzewska A., Espana-Perrot P.P., Venegas-Araneda P., Guzman-Rojas A.M., Gonzalez M.I., Palominos-Rivera M., Irarrazabal C.E., Figueroa-Diesel H., Varas-Godoy M., Illanes S.E. Placental aromatase is deficient in placental ischemia and preeclampsia. PLoS One. 2015, 10(10):e0139682.
42. Qin J.Z., Pang L.H., Li M.J., Fan X.J., Huang R.D., Chen H.Y. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod. Biol. Endocrinol. 2013, 11:56.
43. Recabarren S.E., Smith R., Rios R., Maliqueo M., Echiburu B., Codner E., Cassorla F., Rojas P., Sir-Petermann T. Metabolic profile in sons of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2008, 93(5):1820-1826.
44. Roos N., Kieler H., Sahlin L., Ekman-Ordeberg G., Falconer H., Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011, 343:d6309.
45. Salvesen K.A., Vanky E., Carlsen S.M. Metformin treatment in pregnant women with polycystic ovary syndrome-is reduced complication rate mediated by changes in the uteroplacental circulation?. Ultrasound Obstet. Gynecol. 2007, 29(4):433-437.
46. Sathishkumar K., Elkins R., Chinnathambi V., Gao H., Hankins G.D., Yallampalli C. Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport. Reprod. Biol. Endocrinol. 2011, 9:110.
47. Sathishkumar K., Balakrishnan M., Chinnathambi V., Chauhan M., Hankins G.D., Yallampalli C. Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia. J. Perinatol. 2012, 32(5):328-335.
48. Sharifzadeh F., Kashanian M., Fatemi F. A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy. Gynecol. Endocrinol. 2012, 28(10):834-836.
49. Sir-Petermann T., Maliqueo M., Angel B., Lara H.E., Perez-Bravo F., Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod. 2002, 17(10):2573-2579.
50. Sir-Petermann T., Maliqueo M., Codner E., Echiburu B., Crisosto N., Perez V., Perez-Bravo F., Cassorla F. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007, 92(12):4637-4642.
51. Sir-Petermann T., Codner E., Perez V., Echiburu B., Maliqueo M., Ladron de Guevara A., Preisler J., Crisosto N., Sanchez F., Cassorla F., Bhasin S. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2009, 94(6):1923-1930.
52. Soligo M., Protto V., Florenzano F., Bracci-Laudiero L., De Benedetti F., Chiaretti A., Manni L. The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: analysis by ELISA methods. Brain Res. 2015, 1624:455-468. http://dx.doi.org/10.1016/j.brainres.2015.08.005.
53. Stener-Victorin E., Waldenstrom U., Andersson S.A., Wikland M. Reduction of blood flow impedance in the uterine arteries of infertile women with electro-acupuncture. Hum. Reprod. 1996, 11(6):1314-1317.
54. Stener-Victorin E., Lundeberg T., Waldenstrom U., Manni L., Aloe L., Gunnarsson S., Janson P.O. Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol. Reprod. 2000, 63(5):1497-1503.
55. Stener-Victorin E., Kobayashi R., Kurosawa M. Ovarian blood flow responses to electro-acupuncture stimulation at different frequencies and intensities in anaesthetized rats. Aut. Neurosci. Basic Clin. 2003, 108(1-2):50-56.
56. Stener-Victorin E., Lundeberg T., Cajander S., Aloe L., Manni L., Waldenstrom U., Janson P.O. Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod. Biol. Endocrinol. 2003, 1(1):33.
57. Stener-Victorin E., Fujisawa S., Kurosawa M. Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats. J. Appl. Physiol. 2006, 101(1):84-91.
58. Stener-Victorin E., Jedel E., Janson P.O., Sverrisdottir Y.B. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297(2):R387-R395.
59. Sullivan S.D., Moenter S.M. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(18):7129-7134.
60. Sun M., Maliqueo M., Benrick A., Johansson J., Shao R., Hou L., Jansson T., Wu X., Stener-Victorin E. Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. Am. J. Physiol. Endocrinol. Metab. 2012, 303(11):E1373-E1385.
61. Tometten M., Klapp B.F., Joachim R., Fest S., Zenclussen A.C., Peters E.M., Hertwig K., Arck P.C. Nerve growth factor and its functional receptor TrkA are up-regulated in murine decidual tissue of stress-triggered and substance P-mediated abortion. Am. J. Reprod. Immunol. 2004, 51(1):86-93.
62. Toti P., Ciarmela P., Florio P., Volpi N., Occhini R., Petraglia F. Human placenta and fetal membranes express nerve growth factor mRNA and protein. J. Endocrinol. Invest. 2006, 29(4):337-341.
63. Tripathi R., Rath G., Jain A., Salhan S. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia. Ann. Anat. 2008, 190(5):477-489.
64. Uchida S., Hotta H., Kagitani F., Aikawa Y. Ovarian blood flow is reflexively regulated by mechanical afferent stimulation of hindlimb in non-pregnant anesthetized rats. Aut. Neurosci. Basic Clin. 2003, 106:91-97.
65. Usselman C.W., Wakefield P.K., Skow R.J., Stickland M.K., Chari R.S., Julian C.G., Steinback C.D., Davenport M.H. Regulation of sympathetic nerve activity during the cold pressor test in normotensive pregnant and nonpregnant women. Hypertension 2015, 66(4):858-864.
66. Witham E.A., Meadows J.D., Shojaei S., Kauffman A.S., Mellon P.L. Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in mice. Endocrinology 2012, 153(9):4522-4532.
67. Wu X.Y., Li Z.L., Wu C.Y., Liu Y.M., Lin H., Wang S.H., Xiao W.F. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats. Endocr. J. 2010, 57(3):201-209.
68. Zeisler H., Eppel W., Husslein P., Bernaschek G., Deutinger J. Influence of acupuncture on Doppler ultrasound in pregnant women. Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol. 2001, 17(3):229-232.